Bitigo 8 is a pharmaceutical formulation containing Betahistine dihydrochloride as the active ingredient, designed for controlled release and optimal bioavailability. The tablet is manufactured using advanced excipient blends, including disintegrants, binders, and coatings, to ensure uniformity in dosage and stability under varied storage conditions. The formulation adheres to strict pharmaceutical specifications, with a disintegration time of 15–30 minutes and a dissolution rate of ≥80% within 45 minutes in pH 6.8 buffer. The tablet’s physical properties, such as hardness, weight variation, and friability, are meticulously controlled during production to meet international pharmacopeia standards. The excipients used are sourced from certified suppliers, ensuring compatibility with Betahistine’s chemical stability and minimizing risk of degradation during storage. The formulation is optimized for scalability, enabling consistent quality across large-scale manufacturing runs while maintaining compliance with regulatory requirements.
Manufacturing Capability
Our pharmaceutical manufacturing infrastructure is equipped with state-of-the-art facilities designed to produce high-quality tablets like Bitigo 8. The facility includes a fully automated tablet compression line, including high-speed tablet presses capable of handling large-scale production volumes. Sterile processing is achieved through ISO Class 7 cleanrooms, ensuring contamination-free environments for critical steps such as coating and packaging. All manufacturing processes comply with current Good Manufacturing Practices (cGMP), with rigorous validation of equipment, processes, and materials. The production line supports scalability, enabling seamless transitions from small batch trials to bulk supply for global markets. Quality systems are integrated throughout the manufacturing process, including real-time monitoring of critical parameters such as tablet hardness, thickness, and dissolution profiles. Additionally, the facility is certified for quality management systems, ensuring traceability, documentation, and continuous improvement in pharmaceutical manufacturing.
Available Strengths and Packaging
Composition: Betahistine 8mg Tab
Packaging: 10x10 Alu Alu
Bitigo 8 is available in a single strength of 8mg, formulated to meet the dosage requirements of pharmaceutical applications. The packaging consists of 10x10 blister packs made of aluminum-aluminum (Alu Alu) material, providing robust protection against moisture, light, and physical damage. This packaging format ensures secure storage and transportation, with each blister pack containing 10 tablets. The design is ideal for bulk supply, offering efficient space utilization and ease of handling during distribution. The Alu Alu packaging also supports compliance with regulatory standards for pharmaceutical packaging, ensuring product integrity and shelf-life stability.
Contract Manufacturing / Third Party Manufacturing
As a leading manufacturer, we offer comprehensive contract manufacturing and third-party production services tailored to the needs of pharmaceutical buyers. Our facility is equipped to produce private-label products under a client’s brand, with full flexibility in formulation, packaging, and labeling. We support both small-scale development and large-volume production, ensuring consistency in quality and compliance with global regulatory frameworks. Our team of experts collaborates closely with clients to design formulations, conduct stability studies, and optimize production processes for cost-effectiveness and scalability. Whether you require a customized dosage form or a ready-to-market product, our contract manufacturing capabilities provide a reliable solution for pharmaceutical distributors, exporters, and brand owners seeking to expand their product portfolios.
Quality Assurance
Our quality assurance systems are designed to ensure the highest standards of safety, purity, and consistency in every batch of Bitigo 8. Each production batch undergoes rigorous testing, including high-performance liquid chromatography (HPLC) for active ingredient quantification, dissolution testing to confirm bioavailability, and microbial limit testing to ensure sterility. Analytical validation is performed to verify method accuracy, precision, and reproducibility, aligning with ICH and USP guidelines. Quality control measures are integrated at every stage of manufacturing, from raw material inspection to final product release. Documentation is maintained in compliance with cGMP requirements, ensuring full traceability and audit readiness. Additionally, our facility is equipped with advanced analytical tools to detect impurities, degradation products, and deviations in formulation parameters, ensuring compliance with pharmaceutical quality standards.
Regulatory Compliance
We adhere to stringent regulatory frameworks to ensure our products meet global quality and safety standards. Our manufacturing processes comply with current Good Manufacturing Practices (cGMP), as mandated by the FDA, EMA, and WHO. The facility is certified under ISO 9001 for quality management and ISO 14001 for environmental management, reflecting our commitment to sustainable and compliant operations. Products are manufactured in accordance with WHO guidelines for pharmaceutical production, ensuring adherence to international standards for dosage forms, labeling, and packaging. Additionally, our quality systems are aligned with ICH guidelines, ensuring consistency in analytical methods and regulatory submissions. Compliance with regional regulatory frameworks, including the FDA’s 21 CFR Part 211 and the EMA’s GMP guidelines, enables seamless export and market access for pharmaceutical buyers seeking reliable suppliers.
Global Supply Capability
Our global supply capability is supported by an extensive international distribution network and robust logistics infrastructure, ensuring timely delivery of bulk supply to markets worldwide. We have established partnerships with trusted freight forwarders and customs brokers to facilitate seamless cross-border shipments, complying with import regulations and documentation requirements. The facility’s production capacity allows for large-scale manufacturing, enabling bulk supply to meet the demands of pharmaceutical distributors and exporters. Our supply chain is designed for reliability, with redundant systems in place to mitigate disruptions and ensure continuous availability. Whether you require small-volume trials or large-scale exports, our team works closely with clients to optimize logistics, minimize lead times, and maintain supply chain integrity. This capability positions us as a trusted partner for pharmaceutical buyers seeking dependable and scalable supply solutions.
Why Choose Us
Pharmaceutical distributors, exporters, and contract manufacturing partners choose us for our expertise in high-quality pharmaceutical production, regulatory compliance, and global supply capabilities. Our facility’s adherence to cGMP, ISO standards, and WHO guidelines ensures that products like Bitigo 8 meet the highest quality benchmarks for international markets. The ability to produce private-label and contract-manufactured products offers flexibility for brand owners and distributors seeking to expand their portfolios. Our scalable manufacturing infrastructure supports both small-scale development and bulk supply, enabling cost-effective solutions for diverse market needs. Additionally, our commitment to quality assurance, rigorous testing, and compliance with global regulatory frameworks ensures that clients can trust our products for consistent performance and safety. With a focus on reliability, innovation, and customer-centric solutions, we provide a strategic partnership for pharmaceutical buyers seeking to enhance their market presence.
Bulk Supply Inquiry
We offer reliable bulk supply of Bitigo 8 to meet the demands of pharmaceutical distributors and exporters. For inquiries regarding bulk orders, production timelines, or customization options, please contact us at info@delwishealthcare.com.
FAQs
What is the composition of Bitigo 8?
Bitigo 8 contains Betahistine dihydrochloride at a strength of 8mg per tablet, formulated with excipients to ensure stability and bioavailability.
What packaging options are available for Bitigo 8?
Bitigo 8 is available in 10x10 Alu Alu blister packs, providing secure and moisture-resistant packaging for bulk supply.
Can Bitigo 8 be produced in different strengths?
Currently, Bitigo 8 is manufactured in a single strength of 8mg, tailored for pharmaceutical applications requiring precise dosing.
What quality standards does Bitigo 8 comply with?
Bitigo 8 meets cGMP, WHO, and ISO standards, ensuring compliance with global regulatory requirements for pharmaceutical products.
Is Bitigo 8 suitable for export to international markets?
Yes, Bitigo 8 is manufactured in compliance with FDA, EMA, and WHO guidelines, making it suitable for export to global markets.
Can Bitigo 8 be produced under a private label?
Yes, our contract manufacturing capabilities allow for private-label production, with full customization of packaging and labeling.
What is the production capacity for Bitigo 8?
Our facility supports large-scale production, enabling bulk supply to meet the demands of pharmaceutical distributors and exporters.
How is the quality of Bitigo 8 ensured during manufacturing?
Each batch undergoes rigorous testing, including HPLC, dissolution testing, and microbial analysis, ensuring compliance with pharmaceutical quality standards.
What are the storage conditions for Bitigo 8?
Bitigo 8 should be stored in a cool, dry place, away from moisture and direct sunlight, as per standard pharmaceutical storage guidelines.
Can Bitigo 8 be customized for specific regulatory requirements?
Yes, our team works with clients to ensure compliance with regional regulatory frameworks, including FDA, EMA, and local pharmacopeia standards.
